Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?


KILIÇKAP S., DEMİRKAZIK A., GÜRSOY P. , DEMİRCİ U., ERMAN M., YUMUK P. F. , ...More

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019